Key facts
- This page summarizes Sandra Y. Campos's Form 4 filing for PETMED EXPRESS INC (PETS).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 17 Jan 2025, 19:00.
Sandra Y. Campos - 15 Jan 2025 Form 4 Insider Report for PETMED EXPRESS INC (PETS)
- Reporting relationship
- CEO & President, Director
- Issuer ticker
- PETS
- Reported as of
- 15 Jan 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Jan 2025, 19:00:56 UTC
- Prior SEC filing
- 01 May 2024
- Next SEC filing
- 02 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sandra Y. Campos
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sandra Y. Campos filed Form 4 for PETMED EXPRESS INC (PETS) on 17 Jan 2025.
Change
- Previous filing in this sequence was filed on 01 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PETS
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +146,772
- Change %
- +30%
- Price
- $0.000000
- Shares after
- 638,987
- Date
- 15 Jan 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PETS
transaction
Derivative
Performance Share Units
Award
- Transaction value
- $0
- Shares
- +146,772
- Change %
- Price
- $0.000000
- Shares after
- 146,772
- Date
- 15 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 146,772
- Exercise price
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2024 Omnibus Incentive Plan. One-third of the RSUs vest on each of the first, second and third anniversaries of January 15, 2025, subject to continued employment with the Company through the restricted periods (except as provided in the RSU agreement). Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.
Footnote F2
Performance Share Units ("PSUs") granted pursuant to the Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on December 31, 2027.